Cointime

Stealth BioTherapeutics

company

About

Stealth BioTherapeutics is a clinical-stage biotechnology company focused on genetic diseases.

  • 101 - 250

Highlights

Total Funding Amount
$125M
Funding Rounds
2
Investors
2

Details

Last Funding Type
Post-IPO Debt
Last Funding Money Raised
$25M
Industries
Biopharma,Biotechnology,Pharmaceutical,Therapeutics
Founded date
Jan 1, 2007
Number Of Employee
101 - 250
Operating Status
Active

Stealth is a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction. Mitochondria, found in nearly every cell in the body, are the body's main source of energy production and are critical for normal organ function.

The company was founded in 2007 and is based in Newton, Massachusetts, United States.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$125M
Stealth BioTherapeutics has raised a total of $125M in funding over 2 rounds. Their latest funding was raised on Oct 4, 2021 from a Post-IPO Debt round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 4, 2021 Post-IPO Debt $25M 1 Horizon Technology Finance — Detail
Jun 18, 2018 Convertable Note $100M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Stealth BioTherapeutics is funded by 2 investors. Horizon Technology Finance and Ocean Equity Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Horizon Technology Finance Yes Post-IPO Debt
Ocean Equity Partners — Convertable Note
Cointime
Chủ Đề
Công Ty